Liraglutide
100% Online — No Office Visit Required
Liraglutide (brand name Saxenda) is an earlier GLP-1 receptor agonist with an established clinical track record for weight management. Requires daily injection vs. the weekly schedule of semaglutide.
What Is Liraglutide?
Liraglutide is a GLP-1 receptor agonist with a shorter half-life than semaglutide, requiring daily injections. It has been FDA-approved for obesity management under the brand name Saxenda since 2014.
How OakMD Works
OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in Liraglutide, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.
If you are a candidate, your provider will create a personalized treatment plan and guide you through next steps. There are no in-person visits required.
Common Questions
Is liraglutide as effective as semaglutide?
Generally, semaglutide shows greater weight loss in trials. Liraglutide has a longer track record and may be preferable for some patients based on individual response and provider recommendation.
Ready to Get Started?
Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.
The information provided through the OakMD® website, assessments, product pages, checkout flows, communications, and related services is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Medical Disclaimer: The information provided through the OakMD® website, assessments, product pages, checkout flows, communications, and related services is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Prescription treatment, if any, is provided only after review by a US-licensed provider and only if clinically appropriate. Read the full Medical Disclaimer.